( Bloomberg:460@HK, HongKong:0460 )

News from Sihuan Pharmaceutical Holdings Group Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 27, 2014, 10:04 ET Sihuan Pharmaceutical Announces 2014 Interim Results

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Oct 10, 2013, 09:02 ET CFDA Accepts Sihuan Pharmaceutical's Application for Clinical Trial Approval for Self-Developed Innovative Oncology Drug Pirotinib

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Aug 26, 2013, 06:39 ET Sihuan Pharmaceutical Announces 2013 Interim Results

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical...


Jul 17, 2013, 12:36 ET Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Mar 25, 2013, 03:24 ET Sihuan Pharmaceutical Announces 2012 Annual Results

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Feb 22, 2013, 06:26 ET State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with...


Jan 22, 2013, 08:45 ET State Food and Drug Administration Grants Approval for Clinical Studies to Sihuan Pharmaceutical's Innovative Drug -- Benapenem

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Jan 16, 2013, 07:18 ET Sihuan's Generic Drug Nalmefene Hydrochloride Receives Approval for Pharmaceutical Registration from State Food and Drug Administration

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Nov 20, 2012, 07:58 ET Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with...


Oct 31, 2012, 06:09 ET Sihuan's First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Aug 30, 2012, 21:35 ET Sihuan Pharmaceutical Announces 2012 Interim Results

 Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


May 25, 2012, 08:00 ET Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Mar 19, 2012, 08:43 ET Sihuan Pharmaceutical Announces 2011 Annual Results

Sihuan  Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the...


Mar 11, 2012, 05:00 ET Sihuan Pharmaceutical Achieves Important R&D Breakthrough

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company and...


Nov 17, 2010, 20:03 ET Sihuan Pharmaceutical Obtains 30-Year Exclusive Distribution Rights for One of the Best Selling Cardio-Cerebral Vascular Drugs in China

Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise...